DZ Bank
NKTR icon

DZ Bank’s Nektar Therapeutics NKTR Stock Holding History

DZ Bank’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,492
Closed -$232K – 1038
2024
Q2 		$232K Sell
12,492
-6,750
-35% -$142K ﹤0.01% 841
2024
Q1 		$270K Hold
19,242
– – ﹤0.01% 836
2023
Q4 		$163K Hold
19,242
– – ﹤0.01% 849
2023
Q3 		$172K Hold
19,242
– – ﹤0.01% 834
2023
Q2 		$166K Hold
19,242
– – ﹤0.01% 864
2023
Q1 		$203K Buy
+19,242
New +$582K ﹤0.01% 847

Other funds holding NKTR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

DZ Bank's NKTR Position: Q3 2024 in Review

DZ Bank sold out of Nektar Therapeutics (NKTR) in Q3 2024, closing a stake of 12,492 shares — an estimated $232K sold.

DZ Bank first reported a position in NKTR in Q1 2023 and held it in 6 quarters. The position peaked at $270K in Q1 2024. 138 funds tracked by Wall St. Rank hold NKTR as of Q3 2024.

  • DZ Bank reported no remaining Nektar Therapeutics position as of Q3 2024 after selling out during the quarter.
  • DZ Bank sold 12,492 Nektar Therapeutics shares in Q3 2024, an estimated $232K.
  • DZ Bank first reported a position in Nektar Therapeutics in Q1 2023 and held it in 6 quarters.
  • DZ Bank's Nektar Therapeutics position peaked at $270K in Q1 2024.
  • 138 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2024.

Based on DZ Bank's 13F filing for Q3 2024, filed 14 Nov 2024.